LEADER 00979nam0 22002771i 450 001 UON00404463 005 20231205104711.599 100 $a20120202d1971 |0itac50 ba 101 $aslo 102 $aSK 105 $a|||| 1|||| 200 1 $aSlovenska syntax$fJozef Orlovsky 205 $a3. opravene a doplnene vydanie 210 $aBratislava$cOzbor$d1971 215 $a367 p.$d20 cm. 606 $aLINGUA SLOVACCA$xSINTASSI$3UONC081001$2FI 620 $aSK$dBratislava$3UONL000503 676 $a491.87$cLingua Slovacca$v21 700 1$aORLOVSKY$bJozef$3UONV207323$0707730 712 $aObzor$3UONV274739$4650 801 $aIT$bSOL$c20240220$gRICA 899 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI 912 $aUON00404463 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI SL FL 25 0003 $eSI SL 2360 5 0003 $sBuono 996 $aSlovenska syntax$91343951 997 $aUNIOR LEADER 03256nam 22007935 450 001 9910300344803321 005 20200702195111.0 010 $a1-910315-02-8 024 7 $a10.1007/978-1-910315-02-6 035 $a(CKB)3710000000202413 035 $a(EBL)1782083 035 $a(OCoLC)889312695 035 $a(SSID)ssj0001298877 035 $a(PQKBManifestationID)11709268 035 $a(PQKBTitleCode)TC0001298877 035 $a(PQKBWorkID)11241582 035 $a(PQKB)11730880 035 $a(MiAaPQ)EBC1782083 035 $a(DE-He213)978-1-910315-02-6 035 $a(PPN)17992284X 035 $a(EXLCZ)993710000000202413 100 $a20140717d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aUnderstanding Liver Cancer $eA Tale of Two Diseases /$fby Brian I. Carr 205 $a1st ed. 2014. 210 1$aTarporley :$cSpringer Healthcare Ltd. :$cImprint: Springer Healthcare,$d2014. 215 $a1 online resource (59 p.) 300 $aDescription based upon print version of record. 311 $a1-910315-01-X 320 $aIncludes bibliographical references at the end of each chapters. 327 $aIntroduction to hepatocellular carcinoma -- Clinical disease evaluation -- Management of hepatocellular carcinoma -- The whole patient setting -- New directions -- Addendum. 330 $aUnderstanding Liver Cancer is a concise and up-to-date review, which discusses diagnosis, management, patient care, current and emerging therapies, and useful resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of liver cancer as well as a summary of current therapies will benefit from this succinct text. 606 $aMedicine 606 $aPublic health 606 $aHepatology 606 $aInternal medicine 606 $aOncology 606 $aChemotherapy 606 $aMedicine/Public Health, general$3https://scigraph.springernature.com/ontologies/product-market-codes/H00007 606 $aPublic Health$3https://scigraph.springernature.com/ontologies/product-market-codes/H27002 606 $aHepatology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33088 606 $aInternal Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H33002 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aPharmacotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H69000 615 0$aMedicine. 615 0$aPublic health. 615 0$aHepatology. 615 0$aInternal medicine. 615 0$aOncology. 615 0$aChemotherapy. 615 14$aMedicine/Public Health, general. 615 24$aPublic Health. 615 24$aHepatology. 615 24$aInternal Medicine. 615 24$aOncology. 615 24$aPharmacotherapy. 676 $a610 676 $a613 676 $a614 676 $a615.1 700 $aCarr$b Brian I$4aut$4http://id.loc.gov/vocabulary/relators/aut$0755280 906 $aBOOK 912 $a9910300344803321 996 $aUnderstanding Liver Cancer$91521740 997 $aUNINA